Coronary Artery Ectasia, Efficacy of Various Anti Thrombotic Regimens.
Status:
Not yet recruiting
Trial end date:
2025-08-01
Target enrollment:
Participant gender:
Summary
1. To evaluate short and intermediate clinical outcome of different anti-thrombotic
regimens on major adverse cardiac events (MACE) and quality of life in coronary artery
ectasia patients.
2. To evaluate role of P-selectin as a marker of cardiovascular risk in coronary artery
ectasia.